The global computer vision in healthcare market is witnessing rapid expansion, valued at USD 2.45 billion in 2024, increasing to USD 3.32 billion in 2025, and projected to reach around USD 49.26 billion by 2034. The industry is advancing at a CAGR of 35.25% between 2025 and 2034. Growth is fueled by rising adoption of AI-driven imaging, diagnostics, and surgical solutions, along with government support for healthcare digitization.
Download the free sample and get the complete insights and forecasts report on this market @ https://www.towardshealthcare.com/download-sample/5585
North America dominated the market in 2024, while Asia-Pacific is set to emerge as the fastest-growing region. Key players in the market include Artisight, Caregility Corporation, Google, IBM, Iterative Health, KARL STORZ, Microsoft, NVIDIA, SenseTime, and Viso.AI.
Market Size 2024–2034
In 2024, the computer vision in healthcare market size was calculated at USD 2.45 billion, establishing the foundation of its global expansion.
The market grew further in 2025, reaching USD 3.32 billion, supported by increasing demand for AI-powered diagnostics and digital imaging.
By 2034, the market is projected to expand significantly to USD 49.26 billion, reflecting the widespread adoption of CV solutions in surgeries, patient monitoring, and diagnostic applications.
The CAGR during 2025–2034 is estimated at 35.25%, showcasing one of the fastest-growing segments within healthcare AI technologies.
Market Trends
◉Strategic Collaborations Driving Growth
a. In March 2025, Blaize Holdings, Inc. partnered with alwaysAI to merge advanced CV technologies with edge chipsets and devices.
b. This collaboration enabled real-time deployment of computer vision in enterprises, including healthcare, for more accurate and efficient clinical workflows.
◉Innovation in Operating Room Efficiency
a. In December 2024, KARL STORZ collaborated with Artisight to launch the Pathway.AI platform.
b. The solution was designed to reduce turnover times, automate manual processes, and improve data accuracy in operating rooms, thereby enhancing surgical efficiency.
◉AI-Powered Diagnostic Advancements
a. In January 2023, Microsoft partnered with VinBrain, supported by Vingroup, to use Azure Cognitive Services for CV.
b. This initiative validated deep-learning models such as Florence for diagnostic imaging, improving the accuracy and scalability of AI-driven healthcare solutions.
◉Expansion of Applications in Healthcare
a. CV technologies are increasingly applied in medical imaging, disease monitoring, and symptom tracking.
b. They support automation of processes like cell counting in culture procedures, reducing time and human error.
c. Beyond diagnosis, CV is used in training healthcare professionals to handle emergencies more effectively.
◉Rising Demand from Chronic Disease Burden
a. Increasing prevalence of chronic conditions has encouraged early detection using CV-enabled diagnostic tools.
b. Growing hospitalization rates have also pushed demand for advanced patient care technologies powered by CV.
◉Government and Policy Support
a. Multiple governments are actively funding and promoting the installation of AI-based systems in healthcare.
b. Supportive policies are accelerating integration of CV solutions in hospitals, diagnostic centers, and other healthcare organizations.
AI Impact or Role in the Computer Vision in Healthcare Market
◉Enhancement of Medical Imaging & Diagnostics
a. AI-driven computer vision systems enable healthcare providers to identify subtle abnormalities in medical imaging data such as CT scans, MRI, and X-rays with a precision rate close to 90%.
b. The ability to detect early-stage conditions improves survival rates in chronic diseases such as cancer and cardiovascular disorders.
c. AI algorithms help reduce manual interpretation errors, standardize diagnostic processes, and ensure consistent results across healthcare facilities.
◉Support in Surgeries and Surgical Decision-Making
a. AI-powered CV systems assist surgeons by providing high-resolution visualization of internal organs, blood flow, and potential complications during surgeries.
b. They identify internal bleeding, blocked arteries, or hidden abnormalities in real time, significantly reducing surgical risks.
c. These tools provide predictive insights such as estimating the required amount of blood during surgery, supporting safer decision-making.
◉Personalized Treatments and Precision Medicine
a. CV combined with AI analyzes patient-specific medical history, imaging data, and genetic information to deliver tailored therapies.
b. This reduces unnecessary treatments, lowers risks of side effects, and enhances patient outcomes.
c. AI-integrated CV embedded in MRI and CT tools supports predictive models for disease progression and targeted treatment strategies.
◉Training and Skill Development of Healthcare Professionals
a. CV solutions powered by AI are used in medical education and training, simulating emergencies and surgical procedures.
b. This reduces dependency on live cases and helps doctors practice without risking patient safety.
c. AI-generated CV feedback allows professionals to improve procedural accuracy, enhancing healthcare quality in the long run.
◉Automation and Efficiency in Healthcare Workflows
a. AI-enabled CV systems automate routine tasks such as cell counting in cultures, medication verification, and monitoring patient adherence to treatment regimens.
b. These applications free up time for healthcare staff, allowing them to focus on critical patient care.
c. Mobile CV-enabled apps track whether patients are following prescribed regimens, thus improving recovery outcomes.
◉Improved Patient Safety and Quality of Care
a. With WHO estimating that 1 in 10 patients suffers harm due to unsafe care, AI in CV minimizes surgical errors and improves monitoring during treatment.
b. Real-time alerts in operating rooms and ICUs reduce delays in detecting complications.
c. Enhanced patient safety leads to higher trust in healthcare providers and greater adoption of CV technologies.
Regional Insights
◉North America
a. North America dominated the global market in 2024 due to its advanced healthcare infrastructure, availability of funding, and presence of leading technology companies.
b. The U.S. records more than 4,000 surgical errors annually, which drives the adoption of CV solutions to improve surgical precision.
c. The “Precision Medicine Initiative” in the U.S. fosters research in personalized treatments, strongly aligning with CV-enabled AI technologies.
d. Canada’s “AI4H Guiding Principles” guide provinces in adopting AI responsibly, ensuring ethical deployment and building public trust.
◉Asia-Pacific
a. The region is expected to grow at the fastest rate during the forecast period, driven by rising healthcare expenditure and government support.
b. In China, the launch of the AI-run Robodoc Hospital in December 2024, entirely operated by robots using CV and predictive analytics, exemplifies the region’s leadership in innovation.
c. Japan, through its “Society 5.0” initiative, is integrating AI in healthcare and planning to establish 10 AI-based hospitals, enhancing access to AI-powered diagnostics and treatments.
d. Growing prevalence of chronic diseases like cancer and cardiovascular disorders further accelerates CV adoption in the region.
◉Europe
a. Europe is expected to grow steadily due to heavy investments, awareness of personalized medicine, and government-backed health programs.
b. The EU4Health program (2021–2027) aims to strengthen healthcare resilience and promote digital adoption, encouraging CV technology integration.
c. Germany, as the third-largest medical technology market globally, benefits from the “Digital Act” which accelerates healthcare digitalization and CV adoption.
d. The UK’s rising healthcare expenditure (approx. £292 billion in 2023) and increasing hospital admissions (17.6 million in 2023) create significant demand for AI-integrated CV technologies.
◉Latin America
a. Latin America is projected to grow at a considerable CAGR, with governments and private organizations promoting AI adoption through seminars and collaborations.
b. Argentina introduced a unified digital medical record system and mandated digital prescriptions under Law 27,553, supporting CV-based digital healthcare infrastructure.
c. Brazil leads the region with its national AI strategy, and the Ministry of Health established the Secretariat of Information and Digital Health to promote digital transformation.
d. These initiatives foster conditions for rapid adoption of CV in diagnostics, treatment, and patient monitoring.
Market Dynamics
◉Driver – Increasing Number of Surgeries
a. Globally, over 313 million surgeries are performed annually, creating immense demand for precision technologies like CV.
b. Rising prevalence of chronic diseases and road accidents adds to surgical volumes, pushing hospitals to adopt advanced visualization and monitoring tools.
c. CV helps surgeons reduce errors by identifying bleeding, blocked arteries, and other anomalies in real time.
d. The technology also predicts blood requirements and enhances post-surgical monitoring, improving survival rates.
◉Restraint – Data Privacy Concerns
a. AI-based CV tools rely heavily on patient data, making them vulnerable to cyberattacks.
b. Breaches of sensitive health records pose risks of misuse, undermining patient trust and slowing adoption.
c. Data security compliance requires significant investment, which limits adoption in resource-constrained healthcare systems.
◉Opportunity – Personalized Treatments
a. CV enables precision medicine by analyzing genetic data, imaging results, and patient history to deliver tailored therapies.
b. This reduces unnecessary medication, lowers side effects, and improves treatment efficacy.
c. CV embedded in MRI and CT scans enhances accuracy in identifying complex illnesses and accelerates treatment planning.
d. Governments worldwide are funding personalized medicine research, aligning with the rapid growth of CV technologies.
Top Companies in the Computer Vision in Healthcare Market
◉International Business Machines (IBM) Corporation
a. Overview: IBM is an American multinational technology corporation, well known for its expertise in cloud computing, artificial intelligence, and enterprise solutions.
b. Product/Role in Healthcare: IBM integrates computer vision into its Watson Health solutions, leveraging AI to support imaging analysis and diagnostic accuracy.
c. Strength: IBM’s financial stability underpins its technological advancements. In Q4 2024, revenue reached USD 14.541 billion, a 0.55% increase from Q4 2023. For the full year 2024, IBM’s revenue was USD 62.832 billion, marking a 1.23% year-on-year rise. Its global presence and enterprise AI expertise strengthen its role in healthcare innovation.
◉SenseTime
a. Overview: SenseTime is a Hong Kong-based AI company, recognized for its advanced computer vision platforms.
b. Product/Role in Healthcare: The company’s SenseCare platform applies AI algorithms and image processing to healthcare, enabling diagnostic imaging and clinical decision support.
c. Strength: In 2024, SenseTime’s revenue was RMB 3,772.1 million, growing 10.8% year-on-year. Its specialization in scalable AI platforms makes it a leader in applying CV to healthcare imaging and diagnosis.
◉Artisight
a. Overview: Artisight develops AI-based smart hospital platforms, combining computer vision, IoT, and machine learning to optimize hospital operations.
b. Product/Role in Healthcare: It supports workflow automation, real-time patient monitoring, and surgical coordination through AI-powered CV platforms.
c. Strength: The company’s strong collaborations, including its partnership with KARL STORZ to launch the Pathway.AI platform in 2024, enhance its presence in surgical efficiency solutions.
◉Caregility Corporation
a. Overview: Caregility is a U.S.-based telehealth company that integrates computer vision into virtual care and patient monitoring solutions.
b. Product/Role in Healthcare: Its iObserver platform uses CV to detect fall risks and analyze patient behavior in real-time, running AI entirely on telehealth edge devices in patient rooms.
c. Strength: Caregility’s strength lies in merging telehealth infrastructure with CV, enabling continuous patient observation without overburdening healthcare staff.
◉Google, LLC
a. Overview: Google is a global technology leader with expertise in cloud computing, deep learning, and AI-based healthcare research.
b. Product/Role in Healthcare: Through Google Cloud and AI research, the company applies CV in medical imaging analysis, early detection of diseases, and healthcare predictive analytics.
c. Strength: Its vast cloud ecosystem and AI leadership provide scalability and speed for healthcare providers adopting CV solutions.
◉Microsoft Corporation
a. Overview: Microsoft is a leading global technology provider with strong healthcare AI initiatives.
b. Product/Role in Healthcare: Microsoft Azure Cognitive Services for Computer Vision powers healthcare AI models such as the Florence model, improving diagnostic imaging and clinical validation.
c. Strength: With deep enterprise reach and cloud infrastructure, Microsoft drives global adoption of CV solutions through scalable, secure platforms.
◉NVIDIA Corporation
a. Overview: NVIDIA is the global leader in GPU and AI hardware acceleration.
b. Product/Role in Healthcare: Its GPUs power advanced imaging systems, deep learning models, and real-time CV processing in healthcare.
c. Strength: NVIDIA’s hardware and CUDA software ecosystem form the backbone of AI-driven healthcare applications, offering unmatched speed and accuracy for CV tasks.
◉KARL STORZ
a. Overview: KARL STORZ is a German medical device company specializing in surgical instruments and endoscopy solutions.
b. Product/Role in Healthcare: It integrates CV into surgical visualization and workflow optimization platforms. Its Pathway.AI collaboration with Artisight exemplifies this.
c. Strength: The company’s reputation in surgical technologies gives it a competitive edge in integrating CV into operating rooms.
◉Iterative Health
a. Overview: Iterative Health is a U.S.-based healthcare AI company focused on gastroenterology.
b. Product/Role in Healthcare: It develops CV-powered solutions for endoscopic imaging, improving detection of gastrointestinal diseases such as colorectal cancer.
c. Strength: Its niche focus on gastroenterology provides depth in a critical healthcare specialty, driving adoption of CV for precision diagnostics.
◉Viso.AI
a. Overview: Viso.AI offers computer vision infrastructure platforms for building and deploying AI vision applications.
b. Product/Role in Healthcare: It supports hospitals and diagnostic centers in developing custom CV tools for imaging, monitoring, and research.
c. Strength: The company’s flexible platform approach allows healthcare organizations to adopt and scale AI-based CV without deep technical expertise.
Latest Announcement by Industry Leaders
◉ Roberta Schwartz, Chief Innovation Officer at Houston Methodist Hospital, emphasized the practical benefits of AI-driven computer vision in surgical environments:
a. She explained that real-time insights powered by AI and visuals from ceiling-mounted cameras enable surgeons to prepare better and manage caseloads efficiently.
b. AI was noted to forecast scheduling changes throughout the day, optimizing operating room workflows.
c. These insights improve team coordination and resource productivity, allowing hospitals to increase surgical case volumes without compromising quality of care.
d. Importantly, such systems reduce the burden on perioperative staff, who are often overstressed by manual coordination and unexpected scheduling disruptions.
Recent Developments in the Computer Vision in Healthcare Market
◉University of Auckland Research – May 2024
a. Researchers demonstrated the role of computer vision in identifying abnormalities during surgical procedures.
b. The study showed that CV not only improves intraoperative detection but also supports hospitals burdened by high patient volumes.
c. By enhancing monitoring systems, CV enables remote patient tracking, helping individuals recover safely at home and easing the load on hospital infrastructure.
◉Caregility Corporation – April 2024
a. Caregility launched its iObserver platform, designed to continuously monitor patients at risk of self-harm or falls.
b. The system uses computer vision to analyze visual cues in patient rooms, identifying fall risks and alerting caregivers in real time.
c. iObserver’s unique feature is that AI runs entirely on telehealth edge devices within the patient room, ensuring quick response times without relying on external servers.
d. This innovation aligns with the broader push to integrate AI into telehealth, reducing staffing pressures and ensuring safer patient care.
Segments Covered in the Computer Vision in Healthcare Market
1. By Component
◉Hardware Segment – Dominant in 2024
a. The hardware segment held the leading share of the market in 2024 due to strong healthcare infrastructure and growing investment in advanced diagnostic equipment.
b. Key devices such as X-ray machines, CT scanners, MRI systems, and endoscopy tools are increasingly integrated with computer vision technologies to improve diagnostic accuracy.
c. Researchers are constantly upgrading imaging hardware with CV algorithms to improve visualization, reduce diagnostic errors, and enhance real-time functionality.
d. The rise of wearable medical devices with embedded sensors has also boosted hardware demand, as CV enables remote monitoring of vital signs and patient health.
◉Software Segment – Fastest Growing
a. The software segment is projected to witness significant growth over the forecast period, driven by demand from healthcare professionals working in facilities with limited infrastructure.
b. CV-based software algorithms are cost-effective, user-friendly, and do not require heavy capital investments, making them accessible across hospitals and diagnostic centers.
c. Software plays a critical role in disease detection, surgical guidance, and managing large volumes of clinical trial and imaging data.
d. CV-enabled mobile apps enhance patient adherence by verifying medication intake and treatment compliance, expanding the scope of software solutions.
◉Services Segment – Supportive Growth
a. Services include training, maintenance, and technical support for deploying CV technologies in hospitals and diagnostic centers.
b. Growing outsourcing of AI and computer vision integration to specialized vendors supports this segment.
c. Services also include customization of CV tools to match the needs of healthcare providers, enabling smoother adoption.
2 By Product Type
◉PC-Based Computer Vision Systems – Market Leader in 2024
a. PC-based CV systems dominated the market in 2024 as most healthcare organizations globally are equipped with computer infrastructure.
b. These systems are capable of handling multiple camera inputs and processing complex datasets, making them versatile for diverse clinical applications.
c. PC-based systems also provide higher computational power and flexibility compared to smart cameras, supporting both entry-level and advanced healthcare uses.
◉Smart Camera-Based Computer Vision Systems – Rapid Growth
a. Smart camera-based systems are gaining popularity due to their affordability, simplicity, and independence from specialized installation infrastructure.
b. They are integrated with microprocessors and programmed to handle imaging algorithms directly, reducing reliance on external computing devices.
c. Growing demand is driven by their reliability and ability to streamline imaging tasks in smaller healthcare facilities.
d. Advancements in smart camera technology make them suitable for patient monitoring, fall detection, and bedside diagnostics.
3. By Application
◉Medical Imaging & Diagnostics – Dominant Application in 2024
a. This segment held the largest share of the market in 2024 due to CV’s critical role in automating and improving diagnostic imaging.
b. CV technologies enhance accuracy by detecting minor abnormalities in imaging data that may be overlooked by human eyes.
c. They are widely applied in radiology, oncology, cardiology, and neurology for early disease detection and treatment monitoring.
d. Studies indicate CV can achieve up to 90% accuracy in differentiating medical images, significantly improving clinical decision-making.
◉Surgeries – Fastest Growing Application
a. The surgeries segment is projected to expand rapidly due to the increasing number of global surgeries, estimated at more than 313 million annually.
b. CV assists surgeons in identifying bleeding, blocked arteries, and hidden abnormalities during procedures, reducing error risks.
c. It enables recognition of surgical phases, tools, and anomalies in real time, improving precision and safety.
d. With WHO reporting that unsafe care harms 1 in 10 patients, CV technologies have a strong role in minimizing surgical errors and preventing avoidable fatalities.
◉Patient Management & Research
a. CV aids in monitoring patients post-surgery and during recovery, ensuring safety and faster intervention when complications arise.
b. It is also used in clinical research for analyzing trial data, monitoring medication adherence, and tracking disease progression.
c. In long-term care, CV solutions help in continuous monitoring, reducing the burden on healthcare staff while improving patient outcomes.
◉Others
a. This includes applications in drug discovery, pathology, and epidemic prediction, where CV analyzes vast datasets to assist in preventive measures.
b. It also supports medical training, creating real-time simulations to train healthcare professionals.
4. By End-User
◉Healthcare Providers – Largest Share in 2024
a. Healthcare providers such as hospitals and clinics dominated the market in 2024, adopting CV technologies for early diagnosis, treatment planning, and recovery monitoring.
b. Providers use CV to predict illness risks, improve preventive care, and enhance treatment outcomes.
c. CV also supports training of medical staff, reducing errors and ensuring high-quality care delivery.
◉Diagnostic Centers – Rapid Expansion
a. Diagnostic centers are expected to grow significantly due to their infrastructure and capital capacity to invest in advanced CV-enabled imaging tools.
b. CV assists in quick segmentation and categorization of medical images, increasing diagnostic accuracy in diseases like orthopedic and cardiovascular disorders.
c. Its ability to speed up and automate workflows saves physicians’ time, enabling higher throughput in diagnostic services.
◉Academic Research Institutes
a. Universities and research organizations use CV for developing and validating new imaging models and disease detection algorithms.
b. They also apply CV in experimental studies, drug research, and advanced AI-based healthcare innovations.
◉Others
a. Includes home healthcare services and telehealth platforms using CV-enabled tools for patient monitoring, fall detection, and treatment adherence tracking.
5. By Region
◉North America – Dominant in 2024
a. Strong healthcare infrastructure, presence of major AI companies, and favorable funding policies supported regional dominance.
b. U.S. initiatives like the “Precision Medicine Initiative” drive CV integration for personalized treatments.
c. Canada’s “AI4H Guiding Principles” encourage ethical adoption of CV in healthcare systems.
◉Asia-Pacific – Fastest Growing
a. High population base, rising chronic disease prevalence, and growing awareness of CV technologies drive adoption.
b. China launched Robodoc Hospital in 2024, run entirely by robots using CV and AI, setting a benchmark in healthcare innovation.
c. Japan’s “Society 5.0” initiative promotes AI-based hospitals, boosting CV demand.
◉Europe – Steady Growth
a. The EU4Health program supports digital adoption, resilience, and innovation in healthcare systems.
b. Germany’s “Digital Act” fosters healthcare digitization, while the UK’s high expenditure and hospital admissions push adoption.
◉Latin America – Emerging Market
a. Governments in Argentina and Brazil are advancing digitization and AI adoption in healthcare.
b. Brazil’s Secretariat of Information and Digital Health focuses on digital transformation within public health systems.
◉Middle East and Africa (MEA)
a. Growing investments in digital health infrastructure in countries like UAE, Saudi Arabia, and South Africa are boosting CV adoption.
b. Favorable government strategies aim to modernize healthcare systems with AI-driven technologies.
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5585
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
Web: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
About the Author
